Navigation Links
FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
Date:2/4/2011

BEDFORD, Mass., Feb. 4, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the U.S. Food and Drug Administration (FDA) has approved Hologic's pharmaceutical named Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. Per the terms of an asset purchase agreement (the Agreement) between Hologic and KV Pharmaceutical Company (KV), Hologic will transfer the Company's Makena assets (the Transfer) to KV upon the satisfaction of certain conditions, including receipt of a $12.5 million cash payment from KV. Transfer is expected to be completed by February 11, 2011.

Under the Agreement, Hologic has already received $79.5 million in cash payments from KV, plus reimbursement of Hologic's expenses relating to Makena. In addition to the $12.5 million cash payment expected to be received by February 11, 2011, KV is required to make additional payments to Hologic totaling $107.5 million over a period not to exceed 30 months, which will result in a total purchase price of $199.5 million.

About Hologic, Inc.Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, permanent contraception, osteoporosis assessment, preterm birt
'/>"/>

SOURCE Hologic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women
2. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
3. FDA Approves Viibryd to Treat Major Depressive Disorder
4. FDA Approves Head Lice Treatment for Children and Adults
5. FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
6. VIDEO from Endo Pharmaceuticals Available on thenewsmarket.com: FDA Approves New Treatment for Low Testosterone
7. FDA Approves New Dosage Strength for INTELENCE®
8. U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
9. FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
10. FDA Approves New Manufacturing Facility for Collagenase SANTYL® Ointment
11. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... CHAPEL HILL, N.C. , Aug. 29, 2014 /PRNewswire/ ... the face of regulatory and marketplace changes. CI leaders ... flounder. In a new Best Practices, ... a host of actionable insights, including: - ... and cheaper than primary research - Internal ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PRNewswire/ ... Medina Medical as CEO and member of the Board ... three decades of medical device development and commercialization experience, ... Medical,s field. Mr. Engelson previously served as a Partner ... served as President and CEO of two Foundry start-ups. ...
(Date:8/29/2014)... 2014 Research and Markets  has announced the ... 2014" report to their offering. The ... of the largest segments of pharmaceuticals industry. The numbers of ... available therapies were unable to meet the market requirements. There ... CNS disorder, especially over the past two decades. The market ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2US CNS Disorders Drug Pipeline Insight 2014 2
... Owner Pleads Guilty; Dog Wardens Revoke,Snyder County Kennel ... officials are cracking down on unsatisfactory kennels with ... prosecutor and dog,wardens, Special Deputy Agriculture Secretary for ... dog wardens continue to make progress enforcing current,regulations. ...
... Corp.,(Nasdaq: GENZ ) announced today that the ... trial examining the safety and effectiveness of,Clolar(R) (clofarabine) ... leukemia (AML) who are unlikely to benefit from ... to provide substantial,evidence for expanding the current product ...
Cached Medicine Technology:Dog Law Officers' Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers 2Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 2Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 3Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 4Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 5Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 6
(Date:8/30/2014)... August 30, 2014 McLeod's Sunset Park ... auto repair shop with strong ties to the community celebrates ... happy to announce they have been chosen by The ... for auto repair. , Tim McLeod’s father, Norris (most ... sixty years ago. Although his son, Tim runs the day ...
(Date:8/30/2014)... Franklin, TN (PRWEB) August 30, 2014 ... techniques, including nine mobilizations and six muscle energy techniques. ... also narrates and demonstrates twenty-seven examination techniques for the ... course supports Dr. Reiman's live course presentation with ... Objectives, Applying a differential diagnosis ...
(Date:8/30/2014)... August 30, 2014 What challenges exist ... are the latest trends, concerns, and considerations? Sports ... Ken Pendleton recently spoke with Woody Wommack, Southeast Football ... current issues in football recruiting. Notably, Wommack spoke ... athletes, changes that he thinks are coming as a ...
(Date:8/30/2014)... A new sudden death predictor for patients with ... defibrillators (ICDs) in ESC Guidelines published today. They ... Chairperson Professor Perry Elliott (UK). , The "2014 ... Cardiomyopathy" are published today on-line in the ... ESC Website. Previous ESC Guidelines on hypertrophic cardiomyopathy ...
(Date:8/29/2014)... San Diego (PRWEB) August 30, 2014 ... and their loved ones and caretakers. Author Eddie M. Leung ... with cholangiocarcinoma or bile duct cancer, a very ... “The Year That Changed My Life” (published by Xlibris), he ... but more importantly, he imparts a survivor’s testimony that this ...
Breaking Medicine News(10 mins):Health News:McLeod's Sunset Park Auto Service Celebrates 60 Years Honored with Best of South Tampa 2Health News:North American Seminars Online PT Continuing Education Course, Examination and Treatment of the SI Joint, Receives Continuing Education Approval in NJ, CA, IL, PA, & TX 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 3
... a roadside and rushed to the University of Rochester Medical Center ... doctors were surprised to discover that a trendy tea derived from ... URMC team reported the case study, believed to be the first ... Journal of Emergency Medicine . They described it as ...
... FL (For immediate release) -- Cotinine, a compound derived from ... in a mouse model of Alzheimer,s disease, a study led ... University of South Florida found. The findings are ... in advance of print publication. "We found a compound ...
... the manufacturer of the Alzheimer,s drug memantine submitted a supplementary ... Efficiency in Health Care (IQWiG) sees proof of a benefit ... of a benefit for activities of daily living, at least ... conclusions of the first IQWiG benefit assessment of 2009. IQWiG ...
... Colonoscopy is regarded as the most thorough way ... life-saving procedure can also be painful. Scientists and ... to reduce patient discomfort while also ensuring the ... School of Engineering led by Associate Professor of ...
... Pain researchers from the Sheikh Zayed Institute for Pediatric ... that resiniferatoxin, a drug that has shown early promise as ... body,s ability to fight off bacterial infections, particularly sepsis. ... of the journal Anesthesiology , sheds new light on ...
... percent of American families living above the federal poverty ... the Affordable Care Act, according to a new Commonwealth ... the Massachusetts Institute of Technology (MIT). The report finds ... under the law will make premiums affordable for most ...
Cached Medicine News:Health News:Medical sleuthing linked muscle, kidney problems to kava tea 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 3Health News:Tobacco-derived compound prevents memory loss in Alzheimer's disease mice 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 3Health News:A less painful colonoscopy 2Health News:A less painful colonoscopy 3Health News:Study: Resiniferatoxin may increase sepsis-related mortality 2Health News:New study: Health reform to make health insurance affordable for nearly all families 2
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: